EUVIMEDEUVIMED entdecken
Leserbrief

Spesolimab in refractory paediatric acrodermatitis continua of Hallopeau, a case series

Liting Cai iD, Yunling Yan, Yang Li, Junjie Lin iD, Xinyan She iD, Xiaohua Wang

Journal of the European Academy of Dermatology and Venereology · 2025-06 · 39 (6)

DOI: 10.1111/jdv.20500 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 16.12.2024. Verfasst von Liting Cai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Hospital of Southern Medical University, Guangzhou, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Dermatology Hospital of Southern Medical University, Guangzhou, China.
  • Dermatology Hospital of Fuzhou, Fuzhou, China.

ORCID-Profile: Liting Cai, Junjie Lin, Xinyan She

Zitieren

APA

Cai, L., Yan, Y., Li, Y., Lin, J., She, X., & Wang, X. (2025). Spesolimab in refractory paediatric acrodermatitis continua of Hallopeau, a case series. Journal of the European Academy of Dermatology and Venereology, 39(6). https://doi.org/10.1111/jdv.20500

Vancouver

Cai L, Yan Y, Li Y, Lin J, She X, Wang X. Spesolimab in refractory paediatric acrodermatitis continua of Hallopeau, a case series. Journal of the European Academy of Dermatology and Venereology. 2025;39(6). doi:10.1111/jdv.20500

BibTeX
@article{Cai2025,
  author = {Cai, Liting and Yan, Yunling and Li, Yang and Lin, Junjie and She, Xinyan and Wang, Xiaohua},
  title = {Spesolimab in refractory paediatric acrodermatitis continua of Hallopeau, a case series},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2025},
  volume = {39},
  number = {6},
  doi = {10.1111/jdv.20500}
}
Kostenlos starten →